Premialab, a provider of data, analytics and risk management tools for quantitative investing, has secured a $220 million growth investment led by KKR, with existing backer Balderton also participating. The funding is intended to support Premialab’s next phase of global expansion, accelerate product development, and scale operational systems as the company deepens its footprint in the market for quantitative investment strategies.
Founded in 2016 by Adrien Géliot and Pierre Trecourt, Premialab has built a platform focused on the quantitative investment strategies market, which it estimates at roughly $800 billion in assets under management. The company positions itself as an independent data and analytics standard for QIS by enabling clients to access and benchmark strategies, analyze performance, and use risk analytics designed for systematic investing. Premialab said it has assembled a proprietary database collected directly from major global sell-side investment banks, comprising more than 7,000 QIS strategies, as it seeks to serve as a centralized reference point for institutions evaluating strategy construction and risk.
The company is headquartered in Dubai and operates across New York, London, Paris, Hong Kong and Sydney. Premialab said the new capital will help expand its presence across institutional clients and support the scaling of an execution product it recently launched. That execution offering was codeveloped with Eurex and is designed to broaden access to QIS strategies.
For KKR, the deal extends its technology growth investing activity through its Technology Growth Equity platform, which the firm said has invested about $24 billion in related transactions since 2016. KKR indicated the investment will be made primarily through its Next Generation Technology Growth Fund III and described the transaction as the platform’s first investment in the Gulf region.
Premialab was advised by Rothschild & Co as financial adviser and A&O Shearman as legal adviser. KKR was advised by Gibson Dunn as legal adviser.
KEY QUOTES:
“Quantitative investment strategies have grown rapidly in scale and importance, yet the market has lacked a truly independent standard for data, analytics and risk. Premialab was built to fill that gap. This strategic partnership with KKR marks an important milestone for the business and provides us with the resources and long-term support to accelerate the development of the systematic investing ecosystem. Working closely with banks and strategic partners, we will continue to scale our platform globally, enabling us to better serve clients with deeper analytics, greater transparency and improved efficiency.”
Adrien Geliot, CEO Of Premialab
“We are delighted to enter into this strategic partnership with KKR and to benefit from their deep expertise and strong global capabilities. This investment will enable us to accelerate product development, further enhance our analytics, and expand our presence among institutional clients worldwide. We are particularly excited to continue building out our infrastructure, including our execution offering with Eurex, broadening access to QIS strategies in a more transparent and scalable way.”
Pierre Trecourt, COO Of Premialab
“QIS strategies are rapidly being adopted across customer segments, and Premialab has established itself as the category defining data and analytics platform that is uniquely enabling this ecosystem. The company delivers critical and differentiated data to blue-chip clients globally, with a durable, high value proposition. We’re delighted to strategically partner with the founders and management team at Premialab to accelerate future growth, through this investment and access to our network and resources.”
Elliot Bell, Principal At KKR
“Premialab’s global growth is exceptional and it has become an essential platform for any institutional investor touching QIS. The recent expansion into execution in partnership with Eurex, together with this growth investment from KKR, positions Premialab to build one of the leading companies in capital markets. It has been a privilege to work with Premialab over the last five years and we are excited to continue as an investor for the next chapter.”
Rob Moffat, Partner At Balderton
